Petr Janský

23.6k total citations
44 papers, 1.4k citations indexed

About

Petr Janský is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Petr Janský has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Petr Janský's work include Atrial Fibrillation Management and Outcomes (20 papers), Cardiac Arrhythmias and Treatments (14 papers) and Acute Myocardial Infarction Research (8 papers). Petr Janský is often cited by papers focused on Atrial Fibrillation Management and Outcomes (20 papers), Cardiac Arrhythmias and Treatments (14 papers) and Acute Myocardial Infarction Research (8 papers). Petr Janský collaborates with scholars based in Czechia, United States and United Kingdom. Petr Janský's co-authors include Lars Wallentin, Renato D. Lópes, John H. Alexander, Christopher B. Granger, Elaine M. Hylek, Michael G. Hanna, Claes Held, Laine Thomas, Sigrun Halvorsen and Salim Yusuf and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Petr Janský

38 papers receiving 1.4k citations

Peers

Countries citing papers authored by Petr Janský

Since Specialization

Citations

This map shows the geographic impact of Petr Janský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Janský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Janský more than expected).

Fields of papers citing papers by Petr Janský

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Janský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Janský. The network helps show where Petr Janský may publish in the future.

Co-authorship network of co-authors of Petr Janský

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Janský. A scholar is included among the top collaborators of Petr Janský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Janský. Petr Janský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	(Beta-blockers in the secondary prevention of myocardial infarction with respect to recent results of ABYSS and REDUCE-AMI trials) 2025 ·Cor et Vasa ·Petr Janský	0
2	Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AF 2024 ·Open Heart ·Jelle C L Himmelreich, Saverio Virdone, A. John Camm, Karen S. Pieper, Ralf E. Harskamp, Ali̇ Oto, Barry Jacobson, J.P.S. Sawhney, Toon Wei Lim, Harry Gibbs, Shinya Goto, Sylvia Haas, Keith A.A. Fox, Petr Janský, Freek W.A. Verheugt, Ajay K. Kakkar	0
3	Rhythm versus rate control in patients with newly diagnosed atrial fibrillation – Observations from the GARFIELD-AF registry 2023 ·IJC Heart & Vasculature ·(unknown), Trygve S. Hall, Saverio Virdone, Dan Atar, A. John Camm, Karen S. Pieper, Petr Janský, Sylvia Haas, Shinya Goto, Е. П. Панченко, Gonzalo Barón‐Esquivias, Pantep Angchaisuksiri, Ajay K. Kakkar	3
4	Increasing prevalence of hypertension during long-term follow-up in children with autosomal dominant polycystic kidney disease 2021 ·Pediatric Nephrology ·Tomáš Seeman, Petr Janský, (unknown), Květa Bláhová, (unknown)	2
5	Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data 2021 ·BMJ ·(unknown), Trygve S. Hall, (unknown), (unknown), Saverio Virdone, Karen S. Pieper, Jean‐Yves Le Heuzey, Petr Janský, David Fitzmaurice, Riccardo Cappato, Dan Atar, A. John Camm, Ajay K. Kakkar	9
6	Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF 2019 ·The American Journal of Medicine ·Freek W.A. Verheugt, Giuseppe Ambrosio, Dan Atar, Jean‐Pierre Bassand, A. John Camm, Juan Pablo Costabel, David Fitzmaurice, (unknown), Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Petr Janský, Gloria Kayani, Janina Stępińska, Alexander G.G. Turpie, Martin van Eickels, Ajay K. Kakkar	9
7	Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation 2019 ·JACC: Cardiovascular Interventions ·Jurriën M. ten Berg, (unknown), Jonas Oldgren, Philippe Gabríel Steg, D. A. Zateyshchikov, Petr Janský, Ki‐Bae Seung, Stefan H. Hohnloser, Gregory Y.H. Lip, Matias Nordaby, Eva Kleine, Deepak L. Bhatt, Christopher P. Cannon	6
8	Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation 2018 ·Journal of the American College of Cardiology ·John D. Horowitz, Raffaele De Caterina, Tamila Heresztyn, John H. Alexander, Ulrika Andersson, Renato D. Lópes, Philippe Gabríel Steg, Elaine M. Hylek, Puneet Mohan, Michael G. Hanna, Petr Janský, Christopher B. Granger, Lars Wallentin	31
9	Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry 2017 ·BMJ Open ·A. John Camm, Gabriele Accetta, Wael Al Mahmeed, Giuseppe Ambrosio, Samuel Z. Goldhaber, Sylvia Haas, Petr Janský, Gloria Kayani, Frank Misselwitz, Seil Oh, Ali̇ Oto, Pekka Raatikainen, Jan Steffel, Martin van Eickels, Ajay K. Kakkar	31
10	Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study 2016 ·The Lancet ·Jeff S. Healey, Jonas Oldgren, Michael D. Ezekowitz, Jun Zhu, Prem Pais, Jia Wang, Patrick Commerford, Petr Janský, Álvaro Avezum, Alben Sigamani, Albertino Damasceno, Paul Reilly, Alex Grinvalds, Juliet Nakamya, Akinyemi Aje, Wael Almahmeed, Andrew Moriarty, Lars Wallentin, Salim Yusuf, Stuart J. Connolly	184
11	The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial 2016 ·European Heart Journal ·Roopinder K. Sandhu, Justin A. Ezekowitz, Ulrika Andersson, John H. Alexander, Christopher B. Granger, Sigrun Halvorsen, Michael Hanna, Ziad Hijazi, Petr Janský, Renato D. Lópes, Lars Wallentin	187
12	BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL 2015 ·Journal of the American College of Cardiology ·Roopinder K. Sandhu, Justin A. Ezekowitz, Ulrika Andersson, John H. Alexander, Christopher B. Granger, Sigrun Halvorsen, Michael G. Hanna, Ziad Hijazi, Petr Janský, Renato D. Lópes, Lars Wallentin	6
13	Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? 2015 ·Circulation Cardiovascular Quality and Outcomes ·Gregory Y.H. Lip, S. K. Rushton-Smith, Samuel Z. Goldhaber, David Fitzmaurice, LG Mantovani, Shinya Goto, Sylvia Haas, Jean‐Pierre Bassand, Alan John Camm, Giuseppe Ambrosio, Petr Janský, Wael Al Mahmeed, Seil Oh, Martin van Eickels, Pekka Raatikainen, Jan Steffel, Ali̇ Oto, Gloria Kayani, Gabriele Accetta, Ajay K. Kakkar	62
14	Trends in epidemiology and the treatment of acute coronary syndromes in the Czech Republic: Comparison of the CZECH-1 and CZECH-2 registries 2014 ·Cor et Vasa ·Petr Toušek, David Hořák, František Toušek, Richard Rokyta, Pavel Červinka, Michael Želı́zko, Michael Aschermann, Petr Janský, (unknown), (unknown), Jiří Jarkovský, Petr Widimský	2
15	Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin 2014 ·Journal of the American College of Cardiology ·Elaine M. Hylek, Claes Held, John H. Alexander, Renato D. Lópes, Raffaele De Caterina, Daniel Wojdyla, Kurt Huber, Petr Janský, Philippe Gabríel Steg, Michael G. Hanna, Laine Thomas, Lars Wallentin, Christopher B. Granger	257
16	Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial 2014 ·European Heart Journal ·Sigrun Halvorsen, Dan Atar, H. Yang, R De Caterina, Çetin Erol, David E. Garcı́a, C. B. Granger, Michael G. Hanna, Claes Held, Steen Husted, Elaine M. Hylek, Petr Janský, Renato D. Lópes, (unknown), Laine Thomas, Lars Wallentin	262
17	Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both 2010 ·Circulation ·Michael Böhm, Magnus Baumhäkel, Koon Teo, Peter Sleight, Jeffrey L. Probstfield, Peggy Gao, Johannes F.E. Mann, Rafael Díaz, Gilles R. Dagenais, Garry Jennings, Lisheng Liu, Petr Janský, Salim Yusuf	132
18	The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry 2007 ·International Journal of Cardiology ·Petr Widimský, (unknown), Petr Janský, František Toušek, (unknown), Michael Aschermann	39
19	Thermal, cardiac and adrenergic responses to repeated local cooling 2006 ·Physiological Research ·L Janský, Eva Matoušková, (unknown), S Vybíral, Petr Janský, (unknown), I. Knı́žková, (unknown)	15
20	Effect of Isradipine on 24-H Blood Pressure Profile Demonstrated by Repeated Monitoring 1991 ·American Journal of Hypertension ·Robert Čihák, J Widimský, (unknown), Petr Janský	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact